Employee Fund Iii Lp Galen is 10% at ACURA PHARMACEUTICALS, INC (ACUR). They have made 5 open-market trades across 1 company since 2010, most recently 2015-06-17.
CIK 0001056642
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -17.9% | -9.9% | -9.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACUR | SELL | 2015-06-16 | 2015-06-18 | $1.08 | $113K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2014-02-28 | 2014-03-24 | $2.01 | $43K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-10-10 | 2013-10-11 | $2.05 | $9K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-06-12 | 2013-06-14 | $2.16 | $67K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-05-16 | 2013-05-20 | $2.33 | $388K | -17.9% | -9.9% | -9.9% |
| MDAS | SELL · 10b5-1 | 2010-05-17 | 2010-05-19 | $24.11 | $744K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.